Bacterial Surinfections in COVID-19 ICU Patients
Incidence and Predictive Value of Bacterial Surinfections on In-hospital Mortality in COVID-19 ICU Patients: a Longitudinal Single-center Study
1 other identifier
observational
116
1 country
1
Brief Summary
The aim of this study is to assess the incidence of bacterial surinfections (sepsis, VAP and catheter infections) in COVID-19 patients admitted to the ICU from 13th of March 2020 until 17h of October 2020. In addition, the association of these infections with the dose of corticosteroids, the length of stay in ICU and in hospital, the presence of venous thromboembolism, the number of bacterial episodes, the different types of bacteria causing the infections and ICU mortality will be evaluated as well as the associations between the presences of thrombi and bacteremia/catheter sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 7, 2021
CompletedStudy Start
First participant enrolled
August 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2021
CompletedAugust 30, 2021
August 1, 2021
Same day
May 3, 2021
August 27, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of sepsis
Incidence of bacterial surinfections (sepsis) in COVID-19 patients admitted to the ICU
through study completion, 8 months
Incidence of VAP
Incidence of bacterial surinfections (VAP) in COVID-19 patients admitted to the ICU
through study completion, 8 months
Incidence of bacterial catheter infections
Incidence of bacterial surinfections (catheter infections) in COVID-19 patients admitted to the ICU
through study completion, 8 months
Secondary Outcomes (7)
Correlation with corticosteroids
through study completion, 8 months
Correlation with the length of stay in ICU and hospital
through study completion, 8 months
Correlation with venous thromboembolism
through study completion, 8 months
Correlation with the number of bacterial episodes
through study completion, 8 months
Correlation with the types
through study completion, 8 months
- +2 more secondary outcomes
Eligibility Criteria
All adult COVID-19 patients admitted to the ICU from 13th of March until 17th of October 2020 were included.
You may qualify if:
- All adult COVID-19 patients admitted to the ICU from 13th of March until 17th of October 2020 were included.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa hospital
Hasselt, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 7, 2021
Study Start
August 15, 2021
Primary Completion
August 15, 2021
Study Completion
August 15, 2021
Last Updated
August 30, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share
None sharing